BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10644301)

  • 1. Proton pump inhibitors for Barrett's oesophagus.
    Triadafilopoulos G
    Gut; 2000 Feb; 46(2):144-6. PubMed ID: 10644301
    [No Abstract]   [Full Text] [Related]  

  • 2. Barrett's oesophagus and proton pump inhibitors: a pathological perspective.
    Shepherd NA
    Gut; 2000 Feb; 46(2):147-9. PubMed ID: 10644302
    [No Abstract]   [Full Text] [Related]  

  • 3. How should Barrett's ulceration be treated?
    Peters JH; Wang KK
    Surg Endosc; 2004 Feb; 18(2):338-44. PubMed ID: 14712389
    [No Abstract]   [Full Text] [Related]  

  • 4. Managing Barrett's oesophagus.
    Hebbard GS; Nandurkar S
    Med J Aust; 2004 Apr; 180(8):375-6. PubMed ID: 15089724
    [No Abstract]   [Full Text] [Related]  

  • 5. The Effect of Proton Pump Inhibitors on Barrett's Esophagus.
    Dunbar KB; Souza RF; Spechler SJ
    Gastroenterol Clin North Am; 2015 Jun; 44(2):415-24. PubMed ID: 26021202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical treatment of Barrett's esophagus.
    Spechler SJ
    J Gastrointest Surg; 2000; 4(2):119-21. PubMed ID: 10885955
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dyspepsia and reflux. Systematic literature review from SBU].
    Von Holstein CS; Norlund A
    Lakartidningen; 2007 May 2-8; 104(18):1414-7. PubMed ID: 17550016
    [No Abstract]   [Full Text] [Related]  

  • 8. Does the treatment of proton pump inhibitors reduce dysplasia or adenocarcinoma development in Barrett's esophagus?
    Akın H; Aydın Y
    Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S31-S32. PubMed ID: 29199164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ask the doctor. Do PPI drugs for stomach acid reduce the risk of cancer in people (like me) with Barrett's esophagus?
    Komaroff AL
    Harv Health Lett; 2014 Apr; 39(6):2. PubMed ID: 24873004
    [No Abstract]   [Full Text] [Related]  

  • 10. Medical treatment of Barrett's esophagus: can it prevent cancer?
    Sampliner RE
    Surg Oncol Clin N Am; 2009 Jul; 18(3):503-8. PubMed ID: 19500739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
    Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
    Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter: proton pump inhibitor usage still seems to reduce the risk of high-grade dysplasia and/or oesophageal adenocarcinoma in Barrett's oesophagus.
    Aydin Y; Akin H
    Aliment Pharmacol Ther; 2014 Oct; 40(7):859-60. PubMed ID: 25185738
    [No Abstract]   [Full Text] [Related]  

  • 13. Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma.
    Samuels T; Hoekzema C; Gould J; Goldblatt M; Frelich M; Bosler M; Lee SH; Johnston N
    Ann Otol Rhinol Laryngol; 2015 Nov; 124(11):893-902. PubMed ID: 26077392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From Reflux Esophagitis to Esophageal Adenocarcinoma.
    Souza RF
    Dig Dis; 2016; 34(5):483-90. PubMed ID: 27331918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter: proton pump inhibitor usage still seems to reduce the risk of high-grade dysplasia and/or oesophageal adenocarcinoma in Barrett's oesophagus--authors' reply.
    Hvid-Jensen F; Drewes AM; Funch-Jensen P
    Aliment Pharmacol Ther; 2014 Oct; 40(7):860-1. PubMed ID: 25185739
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of surgical patients with gastroesophageal reflux disease and Barrett's esophagus].
    Zsolt S; Paszt A; Géczi T; Abrahám S; Tóth I; Horváth Z; Pieler J; Tajti J; Varga A; Tiszlavicz L; Németh I; Izbéki F; Rosztóczy A; Wittmann T; Lázár G
    Magy Seb; 2014 Oct; 67(5):287-96. PubMed ID: 25327403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma.
    Thrift AP
    Curr Opin Gastroenterol; 2016 Jul; 32(4):319-24. PubMed ID: 27276368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and prevention of oesophageal adenocarcinoma.
    Ness-Jensen E
    Scand J Gastroenterol; 2022 Aug; 57(8):891-895. PubMed ID: 35234549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Acid Suppression in Barrett's Esophagus.
    Elias PS; Castell DO
    Am J Med; 2017 May; 130(5):525-529. PubMed ID: 28159599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barrett's esophagus: A comprehensive review for the internist.
    Klavan H; Russell MB; Macklin J; Lee E; Aslanian HR; Muniraj T
    Dis Mon; 2018 Nov; 64(11):471-487. PubMed ID: 29880269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.